In addition to teaching and studying the human microbiome in her courses, Dr. Ledgerwood studies host-pathogen interactions of the human virus reovirus, an oncolytic virus that is in phase III clinical trials as a cancer therapeutic for head and neck tumors. She hopes her work will identify key features of tumor cells that can be exploited to improve oncolytic viral therapy.